Indian tariffs on EU pharma and chemical exports will drop to zero from the current 11 per cent and 22 per cent, respectively. The European Union’s (EU’s) offer to ...
New Delhi: Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for biologics and biosimilar drugs to make India a ...
Sun Pharmaceutical Industries Ltd, India’s largest drugmaker by market cap and revenue, is evaluating the acquisition of US-based Organon, a specialist in women’s health with an expanding presence in ...
Textiles, pharmaceuticals, chemicals, engineering goods, gems and jewellery exports will receive a boost from the free trade agreement between India and the 27-nation European Union, according to exporters. Photograph: ...
NEW DELHI: Pharmaceutical experts and the medical technology sector are seeking extension of the production-linked incentive (PLI) scheme to cover active pharmaceutical ingredients (APIs). They also expect the government ...
Emcure Pharmaceuticals on Monday announced the commercial launch of Poviztra, a semaglutide injection for weight loss, across India. With this launch, Emcure becomes the first Indian company to exclusively ...
The Indian government has set a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers.The government imposed the floor price ...
Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA (Tildrakizumab) ...
Aurobindo Pharma is currently incurring a loss at its China-based facility and expects the plant to achieve break-even by the end of the fiscal year, according to its CFO ...
'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going ...